Studies in animal models confirmed a reduced mineralization rate and a reduced trabecular bone volume in T2DM subjects, probably due to the decreased RUNX2 gene expression and reduction of OC, OPG, BMP-2, and ALP expression [18,40,41,42,43,44]. Here, BGLAP is linked to type 2 diabetes mellitus.